Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on: December 20,2023

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on:December 20,2023

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on: December 18,2023

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on:December 18,2023

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new

Updated on: January 05,2024

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new

Updated on:January 05,2024

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo

Updated on: December 22,2023

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo

Updated on:December 22,2023

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on: December 18,2023

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on:December 18,2023

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainSurvivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater preva

Updated on: April 27,2024

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainSurvivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater preva

Updated on:April 27,2024

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on: December 02,2024

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on:December 02,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on: January 05,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on:January 05,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on: March 20,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on:March 20,2024

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on: December 20,2023

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on:December 20,2023

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on: March 14,2024

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on:March 14,2024

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on: August 27,2024

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on:August 27,2024